Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Health/BeautyCosmetic Goods

PUBLISHER: Grand View Research | PRODUCT CODE: 2018357

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2018357

Skin Boosters Market Size, Share & Trends Analysis Report By Ingredient (Hyaluronic Acid, Exosomes, Polycaprolactone), By Gender (Female, Male), By End Use (Dermatology Clinics, MedSpa), By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 108 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Skin Boosters Market Size & Trends:

The global skin boosters market size was estimated at USD 1.53 billion in 2025 and is projected to reach USD 4.09 billion by 2033, growing at a CAGR of 13.1% from 2026 to 2033. Skin boosters are micro-injections of hyaluronic acid, vitamins, and minerals into the epidermis to revitalize, hydrate, and rejuvenate the skin, promoting a natural glow.

The market is expected to grow due to factors such as changing beauty standards across both developed and developing countries, greater financial accessibility to nonsurgical cosmetic procedures, increased regulatory approvals for new-age skin boosters, and rising cosmetic demand from the aging population.

The introduction of various insurance schemes for cosmetic procedures has contributed to the increase in awareness, acceptance, and growth in the skin booster market. For instance, Hamilton Fraser, the UK-based insurance company, is specifically dedicated to providing insurance for a range of aesthetic procedures, including laser treatments, dermal fillers, chemical peels, and facial treatments. Furthermore, in April 2022, AbbVie and PatientFi extended their partnership; as per the agreement, the latter firm agreed to provide financing options to AbbVie's aesthetic product line. Such marketing agreements are expected to boost the demand for the skin booster market during the forecast period.

The growing adoption of minimally invasive cosmetic procedures is expected to drive market growth through the forecast period. The growing popularity of nonsurgical skincare treatment options is one of the primary factors responsible for an increase in the number of patients seeking skin boosters and plastic surgery services. Thus, increased demand for nonsurgical cosmetic procedures can be attributed to greater awareness of the risks and complications associated with invasive surgical procedures, including delayed healing, the risk of incision scars, and adverse reactions to anesthesia.

Increasing emphasis on professional training and skill enhancement for aesthetic practitioners also drives the growth of the skin boosters industry. Advanced injectable treatments require precision and expertise, making structured training programs essential for safe and effective outcomes. For instance, in February 2025, AbbVie announced that its division, Allergan Aesthetics, will launch three new state-of-the-art training centers in the U.S. to expand access to high-quality aesthetics education and hands-on training for providers. This initiative, led by the Allergan Medical Institute (AMI), focuses on improving clinical skills, especially in injectable treatments such as skin boosters, ensuring safer procedures and better patient outcomes. The expansion also strengthens professional training infrastructure, supporting innovation and standardization in aesthetic procedures across key U.S. regions.

Global Skin Boosters Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global skin boosters market report based on ingredient, gender, end use, and region:

  • Ingredient Outlook (Revenue, USD Million, 2021 - 2033)
  • Hyaluronic acid (HA)
  • Polydeoxyribonucleotides (PDRN)
  • Poly-L-Lactic Acid (PLLA)/ Poly-D,L-Lactic Acid (PDLLA)
  • Polycaprolactone (PCL)
  • Exosomes
  • Gender Outlook (Revenue, USD Million, 2021 - 2033)
  • Female
  • Male
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • MedSpa
  • Dermatology Clinics
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68039-911-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Ingredient
    • 1.2.2. Gender
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Ingredient outlook
    • 2.2.2. Gender outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Skin Boosters Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing preference for minimally invasive procedures
      • 3.2.1.2. Increasing public awareness towards aesthetic procedures
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations & approvals
      • 3.2.2.2. Lack of reimbursement
  • 3.3. Skin Boosters Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Skin Boosters Market: Ingredient Estimates & Trend Analysis

  • 4.1. Ingredient Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Skin Boosters Market by Ingredient Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 4.4.1. Hyaluronic acid (HA)
      • 4.4.1.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.2. Polydeoxyribonucleotides (PDRN)
      • 4.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.3. Poly-L-Lactic Acid (PLLA)/ Poly-D,L-Lactic Acid (PDLLA)
      • 4.4.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.4. Polycaprolactone (PCL)
      • 4.4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.5. Exosomes
      • 4.4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Skin Boosters Market: Gender Estimates & Trend Analysis

  • 5.1. Gender Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Skin Boosters Market by Gender Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 5.4.1. Female
      • 5.4.1.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 5.4.2. Male
      • 5.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Skin Boosters Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2025 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Global Skin Boosters Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 6.4.1. Dermatology Clinics
      • 6.4.1.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.4.2. MedSpas
      • 6.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Skin Boosters Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.6. Denmark
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.8. Norway
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
  • 8.4. List of key distributors and channel partners
  • 8.5. Key customers
  • 8.6. Key company market share analysis, 2025
    • 8.6.1. AbbVie, Inc (Allergen)
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. Galderma
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. Sinclair
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. Merz Pharma
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. Teoxane
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. Medytox, Inc.
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. PharmaResearch Co., Ltd.
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. VAIM Co., Ltd
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. Bloomage Biotechnology
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives
    • 8.6.10. IBSA Farmaceutici Italia Srl
      • 8.6.10.1. Company overview
      • 8.6.10.2. Financial performance
      • 8.6.10.3. Product benchmarking
      • 8.6.10.4. Strategic initiatives
    • 8.6.11. Dexlevo Co., Ltd.
      • 8.6.11.1. Company overview
      • 8.6.11.2. Financial performance
      • 8.6.11.3. Product benchmarking
      • 8.6.11.4. Strategic initiatives
    • 8.6.12. LINKUS GLOBAL Co., Ltd.
      • 8.6.12.1. Company overview
      • 8.6.12.2. Financial performance
      • 8.6.12.3. Product benchmarking
      • 8.6.12.4. Strategic initiatives
    • 8.6.13. ExoCoBio Inc.
      • 8.6.13.1. Company overview
      • 8.6.13.2. Financial performance
      • 8.6.13.3. Product benchmarking
      • 8.6.13.4. Strategic initiatives
Show more
Product Code: GVR-4-68039-911-9

List of Tables

  • Table 1 List Of Abbreviation
  • Table 2 North America Skin Boosters Market, By Region, 2021 - 2033 (USD Million)
  • Table 3 North America Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 4 North America Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 5 North America Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 6 U.S. Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 7 U.S. Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 8 U.S. Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 9 Canada Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 10 Canada Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 11 Canada Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 12 Mexico Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 13 Mexico Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 14 Mexico Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 15 Europe Skin Boosters Market, By Region, 2021 - 2033 (USD Million)
  • Table 16 Europe Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 17 Europe Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 18 Europe Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 19 Germany Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 20 Germany Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 21 Germany Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 22 UK Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 23 UK Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 24 UK Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 France Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 26 France Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 27 France Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 28 Italy Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 29 Italy Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 30 Italy Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 31 Spain Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 32 Spain Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 33 Spain Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Denmark Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 35 Denmark Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 36 Denmark Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 37 Sweden Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 38 Sweden Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 39 Sweden Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 40 Norway Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 41 Norway Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 42 Norway Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific Skin Boosters Market, By Region, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 47 China Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 48 China Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 49 China Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Japan Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 51 Japan Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 52 Japan Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 53 India Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 54 India Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 55 India Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 56 Australia Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 57 Australia Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 58 Australia Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 59 South Korea Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 60 South Korea Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 61 South Korea Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Thailand Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 63 Thailand Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 64 Thailand Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 65 Latin America Skin Boosters Market, By Region, 2021 - 2033 (USD Million)
  • Table 66 Latin America Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 67 Latin America Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 68 Latin America Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 69 Brazil Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 70 Brazil Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 71 Brazil Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 72 Argentina Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 73 Argentina Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 74 Argentina Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 MEA Skin Boosters Market, By Region, 2021 - 2033 (USD Million)
  • Table 76 MEA Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 77 MEA Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 78 MEA Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 South Africa Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 80 South Africa Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 81 South Africa Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 82 Saudi Arabia Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 85 UAE Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 86 UAE Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 87 UAE Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)
  • Table 88 Kuwait Skin Boosters Market, By Ingredient, 2021 - 2033 (USD Million)
  • Table 89 Kuwait Skin Boosters Market, By Gender, 2021 - 2033 (USD Million)
  • Table 90 Kuwait Skin Boosters Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Skin Boosters market: market outlook
  • Fig. 14 Skin Boosters competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Skin Boosters market driver impact
  • Fig. 20 Skin Boosters market restraint impact
  • Fig. 21 Skin Boosters market strategic initiatives analysis
  • Fig. 22 Skin Boosters market: Ingredient movement analysis
  • Fig. 23 Skin Boosters market: Ingredient outlook and key takeaways
  • Fig. 24 Hyaluronic acid (HA) market estimates and forecast, 2021 - 2033
  • Fig. 25 Polydeoxyribonucleotides (PDRN) estimates and forecast, 2021 - 2033
  • Fig. 26 Poly-L-Lactic Acid (PLLA)/ Poly-D, L-Lactic Acid (PDLLA) estimates and forecast, 2021 - 2033
  • Fig. 27 Polycaprolactone (PCL) estimates and forecast, 2021 - 2033
  • Fig. 28 Exosomes estimates and forecast, 2021 - 2033
  • Fig. 29 Skin Boosters Market: Gender movement Analysis
  • Fig. 30 Skin Boosters market: Gender outlook and key takeaways
  • Fig. 31 Female market estimates and forecasts, 2021 - 2033
  • Fig. 32 Male market estimates and forecasts, 2021 - 2033
  • Fig. 33 Skin Boosters market: End Use movement analysis
  • Fig. 34 Skin Boosters market: End Use outlook and key takeaways
  • Fig. 35 Dermatology clinics market estimates and forecasts, 2021 - 2033
  • Fig. 36 MedSpas market estimates and forecasts, 2021 - 2033
  • Fig. 37 Global Skin Boosters market: Regional movement analysis
  • Fig. 38 Global Skin Boosters market: Regional outlook and key takeaways
  • Fig. 39 Global Skin Boosters market share and leading players
  • Fig. 40 North America
  • Fig. 41 North America market estimates and forecasts, 2021 - 2033
  • Fig. 42 U.S.
  • Fig. 43 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 44 Canada
  • Fig. 45 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 46 Mexico
  • Fig. 47 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 48 Europe
  • Fig. 49 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 50 UK
  • Fig. 51 UK market estimates and forecasts, 2021 - 2033
  • Fig. 52 Germany
  • Fig. 53 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 54 France
  • Fig. 55 France market estimates and forecasts, 2021 - 2033
  • Fig. 56 Italy
  • Fig. 57 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 58 Spain
  • Fig. 59 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 60 Denmark
  • Fig. 61 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 62 Sweden
  • Fig. 63 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 64 Norway
  • Fig. 65 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 66 Asia Pacific
  • Fig. 67 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 68 China
  • Fig. 69 China market estimates and forecasts, 2021 - 2033
  • Fig. 70 Japan
  • Fig. 71 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 72 India
  • Fig. 73 India market estimates and forecasts, 2021 - 2033
  • Fig. 74 Australia
  • Fig. 75 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 76 South Korea
  • Fig. 77 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 78 Thailand
  • Fig. 79 Thailand market estimates and forecasts, 2021 - 2033
  • Fig. 80 Latin America
  • Fig. 81 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 82 Brazil
  • Fig. 83 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 84 Argentina
  • Fig. 85 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 86 Middle East and Africa
  • Fig. 87 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 88 South Africa
  • Fig. 89 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 90 Saudi Arabia
  • Fig. 91 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 92 UAE
  • Fig. 93 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 94 Kuwait
  • Fig. 95 Kuwait market estimates and forecasts, 2021 - 2033
  • Fig. 96 Market share of key market players- Skin Boosters market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!